Cognitive behavior therapy for comorbid migraine and/or tension-type headache and major depressive disorder: An exploratory randomized controlled trial. (October 2015)

• Record Type: Journal Article
• Authors: Martin, Paul R.; Aiello, Rachele; Gilson, Kathryn; Meadows, Graham; Milgrom, Jeannette; Reece, John
• Is Part Of: Behaviour research and therapy. Volume 73(2015)
• Page Start: 8
• Page End: 18
• Publication Date: 2015-10
• Subjects: Migraine -- Tension-type headache -- Depression -- Cognitive behavior therapy; TTH tension-type headache -- EMG Electromyographic -- CBT cognitive behavior therapy -- RCT randomized controlled trial -- CONSORT Consolidated Standards of Reporting Trials -- RPC routine primary care -- CIDI-LT Composite International Diagnostic Interview 2.1 Auto Lifetime version -- BDI-II Beck Depression Inventory -- BAI Beck Anxiety Inventory -- PHQ-9 Patient Health Questionnaire -- AQoL Australian Quality of Life instrument -- FQ Feedback Questionnaire; Cognitive therapy -- Periodicals; Psychotherapy -- Periodicals; 616.891
• DOI: 10.1016/j.brat.2015.07.005
• Languages: English
• ISSNs: 0005-7967

Abstract

Abstract: Numerous studies have demonstrated comorbidity between migraine and tension-type headache on the one hand, and depression on the other. Presence of depression is a negative prognostic indicator for behavioral treatment of headaches. Despite the recognised comorbidity, there is a limited research literature evaluating interventions designed for comorbid headaches and depression. Sixty six participants (49 female, 17 male) suffering from migraine and/or tension-type headache and major depressive disorder were randomly allocated to a Routine Primary Care control group or a Cognitive Behavior Therapy group that also received routine primary care. The treatment program involved 12 weekly 50-min sessions administered by clinical psychologists. Participants in the treatment group improved significantly more than participants in the control group from pre-to post-treatment on measures of headaches, depression, anxiety, and quality of life. Improvements achieved with treatment were maintained at four month follow-up. Comorbid anxiety disorders were not a predictor of response to treatment, and the only significant predictor was gender (men improved more than women). The new integrated treatment program appears promising and worthy of further investigation. Highlights: Headaches and major depressive disorder are commonly comorbid. This study compared a new cognitive behaviour therapy program with routine primary care. The treatment group was significantly superior in terms of decreases in headaches and depression. The treatment group was also superior on measures of anxiety and quality of life. Improvements achieved were maintained at four month follow-up.